Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor microenvironment: hypoxia and buffer capacity for immunotherapy.

Chenghu Liu1, Shangxian Gao, Zhonghua Qu

  • 1Institute of Immunology, Shandong University, wenhua xilu 44#, Jinan, Shandong province, China.

Medical Hypotheses
|March 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxyalkylation of α-Silylamines via a Photoredox Polarity-Matched Strategy.

Organic letters·2026
Same author

Comparative in vitro and in vivo assessment of three experimental extracellular matrix meshes for soft tissue remodeling.

Scientific reports·2026
Same author

Research on medical students' medical ethics reasoning ability-analysis based on the intermediate concept measurement method.

BMC medical ethics·2026
Same author

[Discussion on the design approach and results evaluation key points of repeated exposure systemic toxicity tests for absorbable medical devices].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi·2026
Same author

[Development Status and Evaluation Strategy Considerations on <i>In Vitro</i> Alternative Methods for Skin Sensitization Testing of Medical Devices].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same author

Cell-penetrating TIPE2 peptide effectively suppresses tumor migration and progression via targeting RAC1.

Cellular signalling·2026

Tumor microenvironment immune cells may form a buffer system crucial for effective anti-tumor immunotherapy. Adjusting immune stimulator dosage, like Corynebacterium parvum, can optimize this buffer capacity for better therapeutic outcomes in malignant melanoma.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Biology

Background:

  • Tumor microenvironment (TME) significantly impacts tumor progression and prognosis.
  • Hypoxia within the TME alters immune cell function, complicating anti-tumor immunotherapy.
  • Current immunotherapy protocols often overlook the TME's immune buffering capacity.

Purpose of the Study:

  • To propose a novel perspective on TME immune interactions as a buffer system.
  • To investigate the impact of immune stimulator dosage on TME immune cells and anti-tumor effects.
  • To guide the development of more effective clinical immunotherapy strategies.

Main Methods:

  • Demonstrated the effect of Corynebacterium parvum on malignant melanoma.
  • Analyzed changes in tumor-infiltrating lymphocytes (TIL) and their anti-tumor effects with varying drug dosages.

Related Experiment Videos

Main Results:

  • Altered dosage of Corynebacterium parvum modified TIL composition and anti-tumor efficacy.
  • The study highlights the importance of immune cell interactions within the TME.

Conclusions:

  • Immune cell interactions in the TME may function as a buffer system critical for immunotherapy.
  • Evaluating a patient's immune buffer capacity is essential before initiating immunotherapy.
  • Optimizing drug dosage to augment the immune buffer system can improve therapeutic outcomes for tumors.